25 assets in Inflammatory Breast Carcinoma

Therapeutic assets addressing Inflammatory Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Inflammatory Breast Carcinoma	Northwestern University	P3	BBB (74)
Cyclophosphamide Inflammatory Breast Carcinoma	Northwestern University	P3	BBB (74)
Trastuzumab Inflammatory Breast Carcinoma	Hoffmann-La Roche	P3	BBB (74)
Pertuzumab Inflammatory Breast Carcinoma	Hoffmann-La Roche	P3	BBB (72)
Adriamycin Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	P3	BB (70)
Epirubicin Inflammatory Breast Carcinoma	Northwestern University	P3	BB (70)
Cis-Diamminedichloroplatinum Ii Inflammatory Breast Carcinoma	RenJi Hospital	P3	BB (68)
Nivestim Inflammatory Breast Carcinoma	Academic and Community Cancer Research United	P2	BB (65)
Trastuzumab Emtansine Inflammatory Breast Carcinoma	Hoffmann-La Roche	P3	B (63)
Olaparib Inflammatory Breast Carcinoma	National Cancer Institute (NCI)	P2	B (60)
Pembrolizumab Inflammatory Breast Carcinoma	Northwestern University	P2	B (60)
Letrozole Inflammatory Breast Carcinoma	RenJi Hospital	P2/3	B (57)
Sargramostim Inflammatory Breast Carcinoma	Academic and Community Cancer Research United	P2	B (57)
Atezolizumab Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	P2	CCC (53)
Cobimetinib Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	P2	CCC (53)
Durvalumab Inflammatory Breast Carcinoma	Filipa Lynce, MD	P2	CCC (53)
Eribulin Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	P2	CCC (53)
Panitumumab Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	P2	CCC (53)
Ruxolitinib Inflammatory Breast Carcinoma	Dana-Farber Cancer Institute	P2	CCC (53)
Trastuzumab Deruxtecan Inflammatory Breast Carcinoma	Filipa Lynce, MD	P2	CCC (53)
Eribulin Monomethanesulfonate Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	P1/2	CCC (48)
Polo-Like Kinase 1 Inhibitor Nms-1286937 Inflammatory Breast Carcinoma	Antonio Giordano, MD	P1/2	CCC (48)
Transferrin Receptor-Targeted Liposomal P53 Cdna Inflammatory Breast Carcinoma	Northwestern University	P1	CC (43)
Grapiprant Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	P1/2	C (39)
Indocyanine Green Inflammatory Breast Carcinoma	M.D. Anderson Cancer Center	N/A	D (30)